相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Microwave assisted synthesis of naphthopyrans catalysed by silica supported fluoroboric acid as a new class of non purine xanthine oxidase inhibitors
Sahil Sharma et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
The Mononuclear Molybdenum Enzymes
Russ Hille et al.
CHEMICAL REVIEWS (2014)
New Insight into Urate-Related Mechanism of Cardiovascular Damage
Davide Grassi et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Synthesis and bioevaluation of 2-phenyl-4-methyl-1,3-selenazole-5-carboxylic acids as potent xanthine oxidase inhibitors
Qi Guan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
1,3,5-Triazine-based analogues of purine: From isosteres to privileged scaffolds in medicinal chemistry
Felicia Phei Lin Lim et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Design, synthesis and molecular modeling of aloe-emodin derivatives as potent xanthine oxidase inhibitors
Da-Hua Shi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Identification of a potent xanthine oxidase inhibitor from oxidation of caffeic acid
Toshiya Masuda et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
The four aldehyde oxidases of Drosophila melanogaster have different gene expression patterns and enzyme substrate specificities
Zvonimir Marelja et al.
JOURNAL OF EXPERIMENTAL BIOLOGY (2014)
Quick identification of xanthine oxidase inhibitor and antioxidant from Erycibe obtusifolia by a drug discovery platform composed of multiple mass spectrometric platforms and thin-layer chromatography bioautography
Zhiyong Chen et al.
JOURNAL OF SEPARATION SCIENCE (2014)
Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia
Thomas M. MacDonald et al.
BMJ OPEN (2014)
The molybdenum oxotransferases and related enzymes
Russ Hille
DALTON TRANSACTIONS (2013)
Aldehyde oxidase and its importance in novel drug discovery: present and future challenges
Enrico Garattini et al.
EXPERT OPINION ON DRUG DISCOVERY (2013)
Interaction between uric acid and endothelial dysfunction predicts new onset of diabetes in hypertensive patients
Francesco Perticone et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
A new lupane triterpene from Tetracera scandens L., xanthine oxidase inhibitor
Mai Thanh Thi Nguyen et al.
NATURAL PRODUCT RESEARCH (2013)
Uric acid as a danger signal in gout and its comorbidities
Kenneth L. Rock et al.
NATURE REVIEWS RHEUMATOLOGY (2013)
Identification of Crucial Amino Acids in Mouse Aldehyde Oxidase 3 That Determine Substrate Specificity
Martin Mahro et al.
PLOS ONE (2013)
Xanthine oxidoreductase-catalyzed reactive species generation: A process in critical need of reevaluation
Nadiezhda Cantu-Medellin et al.
REDOX BIOLOGY (2013)
Mutations Associated with Functional Disorder of Xanthine Oxidoreductase and Hereditary Xanthinuria in Humans
Kimiyoshi Ichida et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
The First Mammalian Aldehyde Oxidase Crystal Structure INSIGHTS INTO SUBSTRATE SPECIFICITY
Catarina Coelho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Flavonoid Glycosides Isolated from Unique Legume Plant Extracts as Novel Inhibitors of Xanthine Oxidase
Chrysoula Spanou et al.
PLOS ONE (2012)
2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
Dinesh Khanna et al.
ARTHRITIS CARE & RESEARCH (2012)
Decreased extra-renal urate excretion is a common cause of hyperuricemia
Kimiyoshi Ichida et al.
NATURE COMMUNICATIONS (2012)
Different inhibitory potency of febuxostat towards mammalian and bacterial xanthine oxidoreductases: insight from molecular dynamics
Hiroto Kikuchi et al.
SCIENTIFIC REPORTS (2012)
Synthesis and xanthine oxidase inhibitory activity of 7-methyl-2-(phenoxymethyl)-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one derivatives
K. R. Sathisha et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
A rational approach for the design and synthesis of 1-acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles as a new class of potential non-purine xanthine oxidase inhibitors
Kunal Nepali et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
3,5,2′,4′-Tetrahydroxychalcone, a new non-purine xanthine oxidase inhibitor
Yanfen Niu et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2011)
Molybdenum enzymes in higher organisms
Russ Hille et al.
COORDINATION CHEMISTRY REVIEWS (2011)
Xanthine oxidoreductase: A journey from purine metabolism to cardiovascular excitation-contraction coupling
Amit Agarwal et al.
CRITICAL REVIEWS IN BIOTECHNOLOGY (2011)
Study on toxicological aspects of crystal-mediated nephrotoxicity induced by FYX-051, a xanthine oxidoreductase inhibitor, in rats
Takeo Shimo et al.
DRUG AND CHEMICAL TOXICOLOGY (2011)
Xanthine oxidase inhibitors: a patent survey
Raj Kumar et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2011)
Nitrite reduction by xanthine oxidase family enzymes: a new class of nitrite reductases
Luisa B. Maia et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2011)
FYX-051: A Novel and Potent Hybrid-Type Inhibitor of Xanthine Oxidoreductase
Koji Matsumoto et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Nitrates and Nitrites in the Treatment of Ischemic Cardiac Disease
Vaughn E. Nossaman et al.
CARDIOLOGY IN REVIEW (2010)
Substrate Orientation and Catalytic Specificity in the Action of Xanthine Oxidase THE SEQUENTIAL HYDROXYLATION OF HYPOXANTHINE TO URIC ACID
Hongnan Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
QM/MM Studies of Xanthine Oxidase: Variations of Cofactor, Substrate, and Active-Site Glu802
Sebastian Metz et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2010)
Crystal Structures of Urate Bound Form of Xanthine Oxidoreductase: Substrate Orientation and Structure of the Key Reaction Intermediate
Ken Okamoto et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Xanthine Nephrolithiasis in a Galician Blond Beef Calf
Marta Miranda et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2010)
Peroxisomes and reactive oxygen species, a lasting challenge
Sabine Angermueller et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2009)
Mechanism of Substrate and Inhibitor Binding of Rhodobacter capsulatus Xanthine Dehydrogenase
Uwe Dietzel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
A Combined QM/MM Study on the Reductive Half-Reaction of Xanthine Oxidase: Substrate Orientation and Mechanism
Sebastian Metz et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout
Owen M. Woodward et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Common Defects of ABCG2, a High-Capacity Urate Exporter, Cause Gout: A Function-Based Genetic Analysis in a Japanese Population
Hirotaka Matsuo et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
Mechanisms Underlying Erythrocyte and Endothelial Nitrite Reduction to Nitric Oxide in Hypoxia Role for Xanthine Oxidoreductase and Endothelial Nitric Oxide Synthase
Andrew J. Webb et al.
CIRCULATION RESEARCH (2008)
Mammalian xanthine oxidoreductase - mechanism of transition from xanthine dehydrogenase to xanthine oxidase
Tomoko Nishino et al.
FEBS JOURNAL (2008)
Elevated Uric Acid Increases the Risk for Kidney Disease
Rudolf P. Obermayr et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout
Veronique Vitart et al.
NATURE GENETICS (2008)
Mechanism of inhibition of xanthine oxidoreductase by allopurinol: Crystal structure of reduced bovine milk xanthine oxidoreductase bound with oxipurinol
Ken Okamoto et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2008)
Substrate orientation in xanthine oxidase - Crystal structure of enzyme in reaction with 2-hydroxy-6-methylpurine
James M. Pauff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Xanthine urolithiasis in a cat: a case report and evaluation of a candidate gene for xanthine dehydrogenase
Shuichi Tsuchida et al.
JOURNAL OF FELINE MEDICINE AND SURGERY (2007)
Nitrite confers protection against myocardial infarction:: Role of xanthine oxidoreductase, NADPH oxidase and KATP channels channels
John E. Baker et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Two mutations convert mammalian xanthine oxidoreductase to highly superoxide-productive xanthine oxidase
Ryosuke Asai et al.
JOURNAL OF BIOCHEMISTRY (2007)
Human xanthine oxidase changes its substrate specificity to aldehyde oxidase type upon mutation of amino acid residues in the active site: Roles of active site residues in binding and activation of purine substrate
Yuichiro Yamaguchi et al.
JOURNAL OF BIOCHEMISTRY (2007)
Prevalence of the metabolic syndrome in patients with gout: The Third National Health and Nutrition Examination Survey
Hyon K. Choi et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Xanthinuria type I: a rare cause of urolithiasis
Nina Arikyants et al.
PEDIATRIC NEPHROLOGY (2007)
Therapeutic effects of xanthine oxidase inhibitors: Renaissance half a century after the discovery of allopurinol
P Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
Molecular characterization of human xanthine oxidoreductase: the enzyme is grossly deficient in molybdenum and substantially deficient in iron-sulphur centres
BLJ Godber et al.
BIOCHEMICAL JOURNAL (2005)
Hyperuricemia induces endothelial dysfunction
UM Khosla et al.
KIDNEY INTERNATIONAL (2005)
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
SL Hung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease
J Kanellis et al.
SEMINARS IN NEPHROLOGY (2005)
Molybdenum-containing hydroxylases
R Hille
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2005)
Xanthine oxicloreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications
CE Berry et al.
JOURNAL OF PHYSIOLOGY-LONDON (2004)
Uric acid: role in cardiovascular disease and effects of losartan
M Alderman et al.
CURRENT MEDICAL RESEARCH AND OPINION (2004)
The role of active site glutamate residues in catalysis of Rhodobacter capsulatus xanthine dehydrogenase
S Leimkühler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Y-700 [1-[3-cyano-4-(2,2-dimethylpropoxy)phenyl]-1H-pyrazole-4-carboxylic acid]:: A potent xanthine oxidoreductase inhibitor with hepatic excretion
A Fukunari et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
The crystal structure of xanthine oxidoreductase during catalysis: Implications for reaction mechanism and enzyme inhibition
K Okamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Ureide biosynthesis in legume nodules
S Tajima et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2004)
An extremely potent inhibitor of xanthine oxidoreductase - Crystal structure of the enzyme-inhibitor complex and mechanism of inhibition
K Okamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Structure and function of xanthine oxidoreductase: Where are we now?
R Harrison
FREE RADICAL BIOLOGY AND MEDICINE (2002)
Crystal structures of the active and alloxanthine-inhibited forms of xanthine dehydrogenase from Rhodobacter capsulatus
JJ Truglio et al.
STRUCTURE (2002)
Characterization of the magnitude and kinetics of xanthine oxidase-catalyzed nitrite reduction - Evaluation of its role in nitric oxide generation in anoxic tissues
HT Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Mutation of human molybdenum cofactor sulfurase gene is responsible for classical xanthinuria type II
K Ichida et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: Structure-based mechanism of conversion
C Enroth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Reduction of nitrite to nitric oxide catalyzed by xanthine oxidoreductase
BLJ Godber et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Sequence motif-specific assignment of two [2Fe-2S] clusters in rat xanthine oxidoreductase studied by site-directed mutagenesis
T Iwasaki et al.
JOURNAL OF BIOCHEMISTRY (2000)
Aldehyde oxidoreductase activity in Desulfovibrio alaskensis NCIMB 13491 -: EPR assignment of the proximal [2Fe-2S] cluster to the Mo site
SLA Andrade et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
分享论文
